MedPath

Tobramycin and Dexamethasone

Tobramycin and Dexamethasone Ophthalmic Suspension Sterile

Approved
Approval ID

8f7f1b78-8ac3-4ba5-b0ec-ca87a433ad39

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 14, 2011

Manufacturers
FDA

H.J. Harkins Company, Inc.

DUNS: 147681894

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code52959-984
Application NumberNDA050592
Product Classification
M
Marketing Category
C73605
G
Generic Name
Tobramycin and Dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateDecember 14, 2011
FDA Product Classification

INGREDIENTS (11)

EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
TOBRAMYCINActive
Quantity: 3 mg in 1 mL
Code: VZ8RRZ51VK
Classification: ACTIB
DEXAMETHASONEActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB
TYLOXAPOLInactive
Code: Y27PUL9H56
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM SULFATEInactive
Code: 0YPR65R21J
Classification: IACT
HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)Inactive
Code: S38J6RZN16
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tobramycin and Dexamethasone - FDA Drug Approval Details